Kowa Research Institute, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.kowaus.com
A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT06525311
- Locations
- 🇺🇸
Southern California Research Center, Inc, Coronado, California, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸Pioneer Research Solutions, Houston, Texas, United States
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
- Conditions
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT06247735
- Locations
- 🇺🇸
UA Thomas D. Boyer Liver Institute, Tucson, Arizona, United States
🇺🇸Southern California Research Center - Coronado, Coronado, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
- Conditions
- Interventions
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT05826353
- Locations
- 🇺🇸
Keck Hospital of USC, Los Angeles, California, United States
🇺🇸Macy Eye Center, Los Angeles, California, United States
🇺🇸Byers Eye Institute at Stanford, Palo Alto, California, United States
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
- Conditions
- Interventions
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05795699
- Locations
- 🇺🇸
Keck Hospital of USC, Los Angeles, California, United States
🇺🇸Macy Eye Center, Los Angeles, California, United States
🇺🇸Jules Stein Eye Institute, Los Angeles, California, United States
Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05722262
- Locations
- 🇺🇸
PPD - Austin Research Unit, Austin, Texas, United States
A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 331
- Registration Number
- NCT05528172
- Locations
- 🇺🇸
Eye Care Specialists, Kingston, Pennsylvania, United States
🇺🇸Center for Sight, Las Vegas, Nevada, United States
🇺🇸Houston Eye Associates, Houston, Texas, United States
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 644
- Registration Number
- NCT05403827
- Locations
- 🇺🇸
Trinity Research Group, Dothan, Alabama, United States
🇺🇸Orange County Ophthalmology Medical Group, Garden Grove, California, United States
🇺🇸LoBue Laser and Eye Medical Center, Murrieta, California, United States
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05327127
- Locations
- 🇺🇸
Boston Clinical Trial Site, Boston, Massachusetts, United States
🇯🇵Nagoya Clinical Trial Site, Nagoya, Aichi, Japan
🇯🇵Toyoake Clinical Trial Site, Toyoake, Aichi, Japan
Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT04742218
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT04484428
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States